Navigation Links
Stantum Offering Demo, Evaluation & Development Board Based on Its Patented Resistive Multi-Touch Technology
Date:9/23/2008

First Such Board on the Market, Stantum's SMK Series Will Let Vendors Cost-Effectively Develop Their Own Resistive Multi-Touch Applications

SAN DIEGO, Sept. 23 /PRNewswire/ -- Stantum Technologies (http://www.stantum.com), a pioneer developer of multi-touch sensing technology, today introduced a demo, evaluation and development board based on its patented PMatrix(TM) resistive multi-touch technology, which lets users simultaneously move an unlimited number of fingers, nails or utensils (such as styli) on a screen.

The first such board on the market, the new SMK series enables vendors and OEMs to evaluate the performance of Stantum's technology and begin developing their own resistive multi-touch applications, thanks to a user-friendly interface compatible with Windows, MAC OS and Linux.

"Stantum is demonstrating that -- contrary to widespread misbelief -- multi-touch is possible with a cost-effective resistive touch-panel platform," said Chris Crotty, director of small and medium displays research at DisplaySearch, a leading provider of information, consulting and conferences on the display supply chain and display-related industries. "With this groundbreaking announcement, Stantum is combining the best of both worlds by offering the features of projected capacitive multi-touch with the lower cost and widespread availability of resistive touch technology."

Added Guillaume Largillier, Stantum's co-founder and CEO: "Our SMK series is the smart multi-touch development kit that the consumer electronics and other industries have long anticipated. It gives manufacturers developing their hardware and applications a great opportunity to assess the huge advantages that multi-touch capability can offer, especially when it uses resistive technology."

SMK boards come with either a 2.5- or 3.5-inch touch-panel sensor; a multi-touch controller; Stantum's Lemurofon software, for demonstrating simple multi-touch applications like games, picture zoom in and out, and keyboard; and a USB port.

SMK multi-touch evaluation and development boards are scheduled to be available Oct. 1. Inquiries can be made via Stantum's web site at http://www.stantum.com/spip.php?page=inquiry.

About Stantum Technologies

Stantum Technologies (formerly JazzMutant) has pioneered multi-touch technologies since its founding in 2002 by Guillaume Largillier and Pascal Joguet. The following year, it developed the world's first multi-touch screen that could track an unlimited number of fingers at once and in 2005 launched Lemur, the first multi-touch product available on the market. Today, Stantum's technology portfolio and product offerings cover every aspect of multi-touch interaction, including sensor design, multi-touch controllers, intellectual property cores, software integration, and application programming interfaces. Stantum is headquartered in Bordeaux, France, with the U.S. accounting for about one-third of its worldwide sales.

Editorial Contact

Neal Leavitt

Leavitt Communications

760-639-2900 or 760-212-9112

neal@leavcom.com


'/>"/>
SOURCE Stantum
Copyright©2008 PR Newswire.
All rights reserved

Related biology news :

1. Positron emission tomography superior to standard evaluation tools in measuring treatment response
2. Gender, coupled with diabetes, affects vascular disease development
3. New target for anti-flu drug development
4. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
5. KAUST and American University in Cairo to collaborate on research and academic development
6. Old developmental pathways spawn revolutionary evolutionary changes
7. NIST announces 56 new awards for innovative technology research and development
8. Progress Against Malaria: Developments on the Horizon
9. Flu vaccine in painless skin patches under development at Emory, Georgia Tech with NIH grants
10. Biopharmaceutical infrastructure key to lower drug development costs
11. Study identifies pathway required for normal reproductive development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2016)... June 20, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring ... involved, it has secured the final acceptance by ... for Managed Access Systems (MAS) installed. Furthermore, Securus ... to be installed by October, 2016. MAS distinguishes ...
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology: